U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Collaborating Centre for Women's and Children's Health (UK). Multiple Pregnancy: The Management of Twin and Triplet Pregnancies in the Antenatal Period. London: RCOG Press; 2011 Sep. (NICE Clinical Guidelines, No. 129.)

  • NICE's original guideline on multiple pregnancy was published in 2011 and updated in 2019. This document preserves evidence reviews and committee discussions for areas of the guideline that were not updated in 2019.

NICE's original guideline on multiple pregnancy was published in 2011 and updated in 2019. This document preserves evidence reviews and committee discussions for areas of the guideline that were not updated in 2019.

Cover of Multiple Pregnancy

Multiple Pregnancy: The Management of Twin and Triplet Pregnancies in the Antenatal Period.

Show details

10Timing of birth

Introduction

It is commonly acknowledged by healthcare professionals that twin and triplet pregnancies tend to come to an end earlier than singleton pregnancies. It is also a widely held, although often contested, view among clinicians that perinatal outcomes in twin and triplet pregnancies worsen with increasing gestational age after 37 weeks. As a result, women with twin and triplet pregnancies are often advised to undergo elective birth without any obvious indication. This review question aims to examine the optimal gestational age for uncomplicated twin and triplet pregnancies.

Review question

What is the optimal timing of delivery in women with uncomplicated multiple pregnancies?

The following subquestions were considered by the GDG:

  • What is the gestational age profile for spontaneous delivery in twin/triplet pregnancies?
  • What is the perinatal mortality and morbidity in spontaneous or uncomplicated delivery in twin/triplet pregnancies at different gestational ages?
  • What is the effectiveness of elective delivery in multiple pregnancies?

Existing NICE guidance

Neither ‘Antenatal care’ (NICE clinical guideline 62)14 nor ‘Intrapartum care’ (NICE clinical guideline 55)82 nor ‘Induction of labour’ (NICE clinical guideline 70)17 covered the management of multiple pregnancies. The last of these (‘Induction of labour’, NICE clinical guideline 70)17 recommends offering induction to women with uncomplicated singleton pregnancies between 41 weeks 0 days and 42 weeks 0 days to avoid the risks associated with prolonged pregnancy, with the exact timing decided according to woman’s preference and local circumstances. It also recommends offering induction of labour, elective caesarean section or expectant management on an individual basis to women with previous caesarean section, and offering information on risks associated with emergency caesarean section and uterine rupture with induction of labour. Maternal request should not be considered as the sole reason for induction of labour, but may be considered after 40 weeks of gestation under exceptional circumstances.

‘Caesarean section’ (NICE clinical guideline 13, currently being updated)18 does not recommend offering routine elective caesarean section in uncomplicated twin pregnancies at term except under research circumstances.

Description of included studies

Gestational age profile for spontaneous birth in twin and triplet pregnancies

One study163 was identified for inclusion in relation to incidence of spontaneous birth in twin and triplet pregnancies by gestational age. This study reported data from all twin births in New South Wales, Australia, for a period of 10 years (1990–1999). No study reporting similar data for spontaneous birth in triplet pregnancies was identified.

Perinatal mortality and morbidity in spontaneous or uncomplicated birth at different gestational ages

No studies were identified for inclusion in relation to perinatal outcomes of spontaneous birth in uncomplicated twin and triplet pregnancies according to gestational age at birth. Two large, population-based studies from Japan and the UK, 164;165 reported data on fetal death rates according to gestational age in multiple (predominantly twin) pregnancies. These studies did not make any distinction between monochorionic and dichorionic twin pregnancies.

To explore the effect of chorionicity on fetal death rates at different gestational ages, six smaller studies reporting data for monochorionic twin pregnancies were identified.166–171 Three of the studies reported data for dichorionic twin pregnancies in the same population.166–168

Neonatal mortality among twins born at different gestational ages was reported in three studies.164;166;170 A Japanese study reported neonatal morbidity according to gestational age at birth in dichorionic twins.172

Two small studies reported fetal death rates at different gestational ages in triplet pregnancies.173;174 In addition, one large study examined US data over 4 years and compared twin and triplet pregnancies to singleton pregnancies for stillbirth and neonatal mortality rates specific to gestational age.159

Effectiveness of elective delivery in twin and triplet pregnancies

Three studies, including one RCT,175 one quasi-randomised trial176 and one retrospective observational study177 were identified that compared elective delivery with expectant management in twin pregnancies. No studies were identified that compared elective delivery with expectant management in triplet pregnancies.

Published health economic evidence

No published health economic evidence was identified, although this question was prioritised for health economic analysis.

Evidence profiles

Evidence profiles for this question are presented in Figures 10.1 to 10.8 and Tables 10.4 to 10.12. Figure 10.1 presents evidence relating to the gestational age profile for spontaneous births in twin pregnancies. Figures 10.2 to 10.8 and Tables 10.4 to 10.9 present evidence relating to fetal deaths and neonatal mortality and morbidity in spontaneous or uncomplicated births at different gestational ages. Tables 10.11 and 10.12 present evidence relating to effectiveness of elective delivery in twin and triplet pregnancies.

Figure 10.1. Evidence profile for timing of birth in spontaneous labour and delivery in uncomplicated twin pregnancies.

Figure 10.1

Evidence profile for timing of birth in spontaneous labour and delivery in uncomplicated twin pregnancies. Source: Roberts, 2002 (n=5930, low quality evidence)

Figure 10.2. Evidence profile for the risk of fetal death in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for twin pregnancies or predominantly twin pregnancies): a) fetal deaths per 1000 fetuses at the start of the given gestational week.

Figure 10.2

Evidence profile for the risk of fetal death in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for twin pregnancies or predominantly twin pregnancies): a) fetal deaths per 1000 fetuses at the start of the given (more...)

Figure 10.3. Evidence profile for the risk of fetal death in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for twin pregnancies or predominantly twin pregnancies): b) fetal deaths per 1000 fetuses at the start of the given gestational week.

Figure 10.3

Evidence profile for the risk of fetal death in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for twin pregnancies or predominantly twin pregnancies): b) fetal deaths per 1000 fetuses at the start of the given (more...)

Figure 10.4. Evidence profile for the risk of neonatal death in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for twin pregnancies or predominantly twin pregnancies): a) early neonatal deaths per 1000 fetuses at the start of the given gestational week.

Figure 10.4

Evidence profile for the risk of neonatal death in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for twin pregnancies or predominantly twin pregnancies): a) early neonatal deaths per 1000 fetuses at the start (more...)

Figure 10.5. Evidence profile for the risk of neonatal death in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for twin pregnancies or predominantly twin pregnancies): b) neonatal deaths per 1000 live births.

Figure 10.5

Evidence profile for the risk of neonatal death in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for twin pregnancies or predominantly twin pregnancies): b) neonatal deaths per 1000 live births. Source (first (more...)

Figure 10.6. Evidence profile for the risk of neonatal death at different gestational ages (studies reporting results for monochorionic and dichorionic twin pregnancies): early neonatal deaths per 1000 live births in monochorionic and dichorionic twin pregnancies.

Figure 10.6

Evidence profile for the risk of neonatal death at different gestational ages (studies reporting results for monochorionic and dichorionic twin pregnancies): early neonatal deaths per 1000 live births in monochorionic and dichorionic twin pregnancies. (more...)

Figure 10.7. Evidence profile for the risk of fetal or neonatal death at different gestational ages (twins versus triplets versus singletons): a) fetal deaths per 1000 births.

Figure 10.7

Evidence profile for the risk of fetal or neonatal death at different gestational ages (twins versus triplets versus singletons): a) fetal deaths per 1000 births. Source (first author, year): Alexander, 2005 (all live births in the USA, 1995–1998, (more...)

Figure 10.8. Evidence profile for the risk of fetal or neonatal death at different gestational ages (twins versus triplets versus singletons): b) neonatal deaths per 1000 live births.

Figure 10.8

Evidence profile for the risk of fetal or neonatal death at different gestational ages (twins versus triplets versus singletons): b) neonatal deaths per 1000 live births. Source (first author, year): Alexander, 2005 (all live births in the USA, 1995–1998, (more...)

Table 10.4. Evidence profile for neonatal morbidity in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for dichorionic twin pregnancies): neonatal morbidity in dichorionic twin pregnancies versus singleton pregnancies.

Table 10.4

Evidence profile for neonatal morbidity in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for dichorionic twin pregnancies): neonatal morbidity in dichorionic twin pregnancies versus singleton pregnancies. (more...)

Table 10.5. Evidence profile for the risk of fetal death by chorionicity at different gestational ages (studies reporting results for monochorionic and dichorionic twin pregnancies).

Table 10.5

Evidence profile for the risk of fetal death by chorionicity at different gestational ages (studies reporting results for monochorionic and dichorionic twin pregnancies).

Table 10.6. Evidence profile for the risk of fetal death at different gestational ages (studies reporting results for monochorionic twin pregnancies).

Table 10.6

Evidence profile for the risk of fetal death at different gestational ages (studies reporting results for monochorionic twin pregnancies).

Table 10.7. Evidence profile for the risk of fetal death at different gestational ages (studies reporting results for dichorionic twin pregnancies).

Table 10.7

Evidence profile for the risk of fetal death at different gestational ages (studies reporting results for dichorionic twin pregnancies).

Table 10.8. Evidence profile for the risk of neonatal death at different gestational ages (studies reporting results for monochorionic twin pregnancies).

Table 10.8

Evidence profile for the risk of neonatal death at different gestational ages (studies reporting results for monochorionic twin pregnancies).

Table 10.9. Evidence profile for the risk of fetal death at different gestational ages (studies reporting results for triplet pregnancies).

Table 10.9

Evidence profile for the risk of fetal death at different gestational ages (studies reporting results for triplet pregnancies).

Table 10.10. Evidence profile for neonatal morbidity in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for triplet pregnancies): neonatal morbidity in triplet pregnancies according to gestational age at birth.

Table 10.10

Evidence profile for neonatal morbidity in spontaneous or uncomplicated birth at different gestational ages (studies reporting results for triplet pregnancies): neonatal morbidity in triplet pregnancies according to gestational age at birth.

Table 10.11. GRADE summary of findings for comparison between elective birth and expectant management based on dichotomous outcome measures.

Table 10.11

GRADE summary of findings for comparison between elective birth and expectant management based on dichotomous outcome measures.

Table 10.12. GRADE summary of findings for comparison between elective birth and expectant management based on continuous outcome measures.

Table 10.12

GRADE summary of findings for comparison between elective birth and expectant management based on continuous outcome measures.

Table 10.1. Relative risk of fetal death in predominately twin pregnancies compared with fetal death at 42 weeks of gestation or more in singleton pregnancies in the same population.

Table 10.1

Relative risk of fetal death in predominately twin pregnancies compared with fetal death at 42 weeks of gestation or more in singleton pregnancies in the same population.

Table 10.2. Relative risk of fetal death in predominately twin pregnancies compared with fetal death at 42 weeks of gestation or more in singleton pregnancies in the same population.

Table 10.2

Relative risk of fetal death in predominately twin pregnancies compared with fetal death at 42 weeks of gestation or more in singleton pregnancies in the same population.

Table 10.3. Relative risk of early neonatal death in predominately twin pregnancies compared with early neonatal death at 37 weeks of gestation in the same population.

Table 10.3

Relative risk of early neonatal death in predominately twin pregnancies compared with early neonatal death at 37 weeks of gestation in the same population.

Evidence statement

Gestational age profile for spontaneous birth in twin and triplet pregnancies

One cross-sectional study (low quality evidence) suggested that the majority (58%) of women with uncomplicated twin pregnancies give birth spontaneously before 37 weeks 0 days. No robust data were identified for the gestational age profile in spontaneous triplet births.

Perinatal mortality and morbidity in spontaneous or uncomplicated birth at different gestational ages

No evidence was identified for perinatal outcomes at different gestational ages in uncomplicated twin or triplet pregnancies with spontaneous onset of labour.

Indirect evidence from studies reporting all multiple pregnancies together (uncomplicated, spontaneous onset of labour or otherwise) demonstrated an increase in the risk of fetal death per week towards the end of pregnancy. In the largest study of multiple pregnancies (predominantly dichorionic twin pregnancies), the relative risk of fetal death per week of gestation compared to the risk in singleton pregnancies at 42 or more weeks of gestation rose significantly from 37 weeks (low quality evidence). In the same study, early neonatal mortality (death within 7 days of live birth) showed similar trends, with the lowest death rate being reported in twins born at 37 weeks of gestation (low quality evidence).

Most studies that reported fetal or neonatal death rates separately for different types of multiple pregnancy (monochorionic twin, dichorionic twin or triplet pregnancies) were underpowered to detect differences in death rates between clinically important gestational ages (for example between fetal death rates at a given gestational age and those at 37 weeks 0 days to 37 weeks 6 days). The fetal death rate in monochorionic twin pregnancies was significantly higher than that in dichorionic twin pregnancies at 36 weeks or more, and point estimates of relative risk of fetal death were greater than one at all gestational ages (very low quality evidence). In monochorionic twin pregnancies and dichorionic twin pregnancies, fetal death rates were consistently lower at gestational ages between 26 weeks and 35 weeks compared to 36 weeks or more, although not significantly lower (very low quality evidence). In triplet pregnancies, fetal death rates were consistently lower at 33 weeks to 36 weeks compared with 37 weeks or more, and significantly lower at 34 weeks (very low quality evidence). In monochorionic twin pregnancies, neonatal death rates were significantly higher at gestational ages up to 29 weeks compared with 37 weeks or more, and the rates declined further from 30 to 35 weeks (very low quality evidence). In one study involving triplet pregnancies, no serious neonatal morbidity (respiratory distress syndrome, chronic lung disease, intraventricular haemorrhage grades 3 or 4, necrotising enterocolitis or proliferative retinopathy of prematurity) was reported after 34 weeks (very low quality evidence).

Effectiveness of elective delivery in twin and triplet pregnancies

Three studies showed no clinically significant difference in neonatal or maternal outcomes between women with twin pregnancies who underwent elective delivery and those who underwent expectant management (low to high quality evidence).

No studies were identified that examined effectiveness of elective delivery in women with triplet pregnancies.

Health economics profile

No published health economic evidence was identified, although this question was prioritised for health economic analysis. The analysis undertaken for this guideline evaluated the cost effectiveness of offering birth at 37 weeks 0 days for multiple pregnancies compared to delaying birth (expectant management). The economic evaluation suggested that there would be QALY (quality adjusted life year) losses associated with increased fetal mortality and increased neonatal morbidity if multiple pregnancies were managed expectantly beyond 37 weeks 0 days. Expectant management beyond 37 weeks 0 days would also be likely to increase costs, with any decrease in costs of elective birth (via induction of labour or caesarean section) being offset by further monitoring costs in addition to ‘downstream’ costs associated with worse outcomes. Thus, the strategy of offering birth at 37 weeks 0 days is likely to be less costly as well as producing greater health benefits. Elective birth is therefore deemed to be cost effective, dominating a strategy of expectant management.

The health economic analysis was based on a study which included all types of multiple pregnancy,164 although the majority were dichorionic twin pregnancies. There were no sufficiently robust data to conduct separate health economic analyses for monochorionic twin pregnancies or triplet pregnancies. The GDG decided to recommend elective birth before 37 weeks 0 days for these types of multiple pregnancy. The increasing risk of fetal death towards the end of pregnancy seems to be even more pronounced in monochorionic twin pregnancies than in dichorionic twin pregnancies, and the GDG’s view was, therefore, that women with monochorionic twin pregnancies should be offered elective birth at 36 weeks 0 days.

In triplet pregnancies there is a high risk of spontaneous preterm labour and birth occurring in an adverse setting if a pregnancy is managed expectantly towards the end of the third trimester. Furthermore, the clinical evidence suggests that there is a higher risk of fetal death after 34 weeks in triplet pregnancies, and the GDG’s view was, therefore, that women with triplet pregnancies should be offered elective birth at 35 weeks 0 days. While not formally assessed in health economic analysis, these clinical risks would tend to make an earlier timing of elective birth more cost effective, providing that some of the benefits of earlier birth were not completely offset by a higher risk of respiratory morbidity.

Further details of the health economic model are presented in Section 11.3.

Evidence to recommendations

Relative value placed on the outcomes considered

The following were considered to be critical outcomes for this review question:

  • perinatal mortality, neonatal mortality or stillbirth
  • neonatal respiratory problems
  • admission to a neonatal unit
  • neonatal encephalopathy
  • maternal morbidity (such as postpartum haemorrhage requiring blood transfusion, hypertension)
  • operative delivery (instrumental delivery or caesarean section)
  • Apgar score
  • birthweight.

Trade-off between clinical benefits and harms

The evidence reviewed by the GDG indicated that 58% of women with twin pregnancies give birth spontaneously before 37 weeks 0 days. No comparable evidence was identified for triplet pregnancies; however, the GDG is aware of literature suggesting that about 75% of women with triplet pregnancies give birth spontaneously before 35 weeks 0 days.179 The baseline risks of spontaneous preterm birth and its consequences, especially for babies, and the comparative risks of fetal death at increasing gestational ages are the main focus of attention in this review question, which seeks to identify the optimal timing of birth for women with twin and triplet pregnancies. For twin pregnancies the main clinical harm is the increasing risk of fetal death towards the end of pregnancy; this appears to be disproportionately greater in monochorionic twin pregnancies. Hence the GDG’s view was that women with dichorionic twin pregnancies should be offered elective birth at 37 weeks 0 days, whereas those with monochorionic twins should be offered elective birth at 36 weeks 0 days.

For triplets there are two clinical risks with continuing pregnancy towards the end of the third trimester. One is the risk of spontaneous preterm labour and delivery occurring in an adverse setting, the other is a significantly higher risk of fetal death after 34 weeks 6 days. Thus, the GDG’s view was that women with triplet pregnancies should be offered birth at 35 weeks 0 days.

The main trade-offs between clinical benefits and harms for women with twin and triplet pregnancies who have not given birth spontaneously at a given gestational age are the risks of neonatal mortality and morbidity or maternal operative delivery associated with elective delivery versus the risks of fetal death (stillbirth) from continued pregnancy. The GDG acknowledged that the evidence regarding neonatal morbidity associated with elective birth in twin and triplet pregnancies was limited and further research is needed.

It would be helpful in clinical practice to inform women of the absolute risks of fetal death in twin and triplet pregnancies. While this is possible for twin pregnancies (using the fetal death rate per 1000 fetuses for a given gestational period), it is not possible for triplet pregnancies (because the rates are available only as fetal deaths per 1000 live births). The GDG’s view is that it would be confusing to quote absolute fetal death rates for twin and triplet pregnancies in different units. This is why the GDG’s recommendations do not include absolute fetal death rates.

Trade-off between net health benefits and resource use

The health economic analysis conducted for this review question showed that prolonging twin pregnancies beyond 37 weeks 0 days and triplet pregnancies beyond 35 weeks 0 days would incur the loss of health benefits (QALYs), albeit at an increasing cost, and this would not represent value for money. To maximise health benefits in uncomplicated twin and triplet pregnancies, birth should be at 36 weeks 0 days in dichorionic pregnancies, 37 weeks 0 days in monochorionic twin pregnancies and 35 weeks 0 days in triplet pregnancies. This is expected to result in cost savings to the NHS. The GDG recognised that it may be appropriate to offer birth even earlier than 37 weeks 0 days, 36 weeks 0 days, or 35 weeks 0 days if clinically indicated.

Quality of evidence

The evidence ranged in quality from very low to moderate. The best available evidence was sufficient to demonstrate that elective birth by 37 weeks 0 days would be cost effective for all types of multiple pregnancy. Observational studies that reported fetal or neonatal death rates separately for different types of multiple pregnancy were underpowered to detect differences in death rates between clinically important gestational ages (for example, between fetal death rates at a given gestational age and those at 37 weeks 0 days to 37 weeks 6 days), and so recommendations for elective birth at 36 weeks 0 days in monochorionic twin pregnancies and 35 weeks 0 days in triplet pregnancies incorporated consideration of current practice in addition to the available evidence. Further research is needed to determine precisely the optimal timing of birth according to chorionicity and multiplicity of the pregnancy.

Other considerations

The GDG recognised the importance of offering antenatal administration of corticosteroids for elective preterm birth in monochorionic twin pregnancies and triplet pregnancies. The specialist team should discuss with all women with twin and triplet pregnancies the possibility of their babies being admitted to a special care unit if they have a spontaneous preterm birth or if the offer of elective preterm birth is accepted. The GDG also recognised the importance of ensuring that ongoing care is provided for women with twin and triplet pregnancies who decline the offer of elective early birth. No evidence was identified in relation to the optimal surveillance strategy for pregnancies that continue beyond 37 weeks 0 days, 36 weeks 0 days or 35 weeks 0 days in dichorionic twins, monochorionic twins and triplets, respectively. The GDG’s recommendation for weekly appointments with the specialist obstetrician, with weekly biophysical profile testing of all fetuses and fortnightly growth scans, was based on the GDG members’ collective experience.

The possibilities for elective birth are induction of labour or caesarean section. Consideration of mode of delivery is outside the scope of this guideline (because it relates to intrapartum care, not antenatal care), although the GDG was aware that in triplet pregnancies, for example, caesarean section is currently used more frequently than induction of labour. The footnotes to the recommendations relating to timing of birth emphasise that mode of delivery is outside the scope of the guideline.

The GDG highlighted the importance of a member of the core team starting discussions and planning regarding timing of birth and mode of delivery before the time at which elective birth would occur if the offer was accepted.

Recommendations

NumberRecommendation
55Discuss with women with twin and triplet pregnancies the timing of birth and possible modes of delivery** early in the third trimester.
56Inform women with twin pregnancies that about 60% of twin pregnancies result in spontaneous birth before 37 weeks 0 days.
57Inform women with triplet pregnancies that about 75% of triplet pregnancies result in spontaneous birth before 35 weeks 0 days.
58Inform women with twin and triplet pregnancies that spontaneous preterm birth and elective preterm birth are associated with an increased risk of admission to a special care baby unit.
59Inform women with uncomplicated monochorionic twin pregnancies that elective birth from 36 weeks 0 days does not appear to be associated with an increased risk of serious adverse outcomes, and that continuing uncomplicated twin pregnancies beyond 38 weeks 0 days increases the risk of fetal death.
60Inform women with uncomplicated dichorionic twin pregnancies that elective birth from 37 weeks 0 days does not appear to be associated with an increased risk of serious adverse outcomes, and that continuing uncomplicated twin pregnancies beyond 38 weeks 0 days increases the risk of fetal death.
61Inform women with triplet pregnancies that continuing uncomplicated triplet pregnancies beyond 36 weeks 0 days increases the risk of fetal death.
62Offer women with uncomplicated:
  • monochorionic twin pregnancies elective birth* from 36 weeks 0 days, after a course of antenatal corticosteroids has been offered
  • dichorionic twin pregnancies elective birth* from 37 weeks 0 days
  • triplet pregnancies elective birth* from 35 weeks 0 days, after a course of antenatal corticosteroids has been offered.
63For women who decline elective birth, offer weekly appointments with the specialist obstetrician. At each appointment offer an ultrasound scan, and perform weekly biophysical profile assessments and fortnightly fetal growth scans.
**

Specific recommendations about mode of delivery are outside the scope of this guideline.

*

Specific recommendations about mode of delivery are outside the scope of this guideline.

NumberResearch recommendation
RR 17What is the incidence of perinatal and neonatal morbidity and mortality in babies born by elective birth in twin and triplet pregnancies?

Why this is important
The existing evidence in relation to perinatal and neonatal outcomes associated with elective birth in twin and triplet pregnancies is limited in quantity and quality. Evidence suggests a consistently higher fetal death rate (at all gestational ages) in monochorionic twin pregnancies than in dichorionic twin pregnancies. It is uncertain whether elective birth in monochorionic twin pregnancies at 1 week earlier than recommended in the guideline (that is, from 35 weeks 0 days) would reduce fetal death rates significantly without increasing adverse neonatal outcomes significantly (for example, immaturity of the babies’ respiratory systems). The research could be conducted through national audits of perinatal and neonatal morbidities in babies born by elective birth in twin and triplet pregnancies, taking account of the chorionicity of the pregnancy and gestational age at birth. If data from more than one study were available, then the technique of meta-regression might be useful for determining the optimal timing of birth precisely (according to gestational age).
Copyright © 2011, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

Bookshelf ID: NBK83107

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (5.3M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...